Literature DB >> 20206289

Nanonization strategies for poorly water-soluble drugs.

Huabing Chen1, Chalermchai Khemtong, Xiangliang Yang, Xueling Chang, Jinming Gao.   

Abstract

Poor water solubility for many drugs and drug candidates remains a major obstacle to their development and clinical application. Conventional formulations to improve solubility suffer from low bioavailability and poor pharmacokinetics, with some carriers rendering systemic toxicities (e.g. Cremophor(®) EL). In this review, several major nanonization techniques that seek to overcome these limitations for drug solubilization are presented. Strategies including drug nanocrystals, nanoemulsions and polymeric micelles are reviewed. Finally, perspectives on existing challenges and future opportunities are highlighted. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206289     DOI: 10.1016/j.drudis.2010.02.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  83 in total

Review 1.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

3.  A novel three-dimensional large-pore mesoporous carbon matrix as a potential nanovehicle for the fast release of the poorly water-soluble drug, celecoxib.

Authors:  Yanzhuo Zhang; Hong Wang; Chuanjun Li; Baoxiang Sun; Yu Wang; Siling Wang; Cunqiang Gao
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

4.  Turbidity spectroscopy for characterization of submicroscopic drug carriers, such as nanoparticles and lipid vesicles: size determination.

Authors:  Mustafa M A Elsayed; Gregor Cevc
Journal:  Pharm Res       Date:  2011-05-17       Impact factor: 4.200

5.  Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form.

Authors:  Sumita Singh; Kamla Pathak; Vikas Bali
Journal:  AAPS PharmSciTech       Date:  2012-09-11       Impact factor: 3.246

6.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

7.  Formulation and stability testing of itraconazole crystalline nanoparticles.

Authors:  Alia A Badawi; Mohamed Ahmed El-Nabarawi; Doaa Ahmed El-Setouhy; Sami Ahmed Alsammit
Journal:  AAPS PharmSciTech       Date:  2011-06-25       Impact factor: 3.246

Review 8.  Nanoparticles containing insoluble drug for cancer therapy.

Authors:  Shutao Guo; Leaf Huang
Journal:  Biotechnol Adv       Date:  2013-10-08       Impact factor: 14.227

9.  Layer-by-layer nanoencapsulation of camptothecin with improved activity.

Authors:  Gaurav Parekh; Pravin Pattekari; Chaitanya Joshi; Tatsiana Shutava; Mark DeCoster; Tatyana Levchenko; Vladimir Torchilin; Yuri Lvov
Journal:  Int J Pharm       Date:  2014-02-06       Impact factor: 5.875

10.  Nanosuspended branched chain amino acids: the influence of stabilizers on their solubility and colloidal stability.

Authors:  Chi Rac Hong; Gyu Whan Lee; Hyun-Dong Paik; Pahn-Shick Chang; Seung Jun Choi
Journal:  Food Sci Biotechnol       Date:  2017-05-29       Impact factor: 2.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.